Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmaceuticals erythromycin

NMR, 4, 575 Erythritol, 1,4-anhydro-structure, 4, 546 Erythromycin antibacterial veterinary use, 1, 206 as pharmaceutical, 1, 153 synthesis, 1, 480 Erythropterin biosynthesis, 3, 321 occurence, 3, 323 structure, 3, 276 synthesis, 3, 289 Erythropterin, 3,5-dimethyl-methyl ester synthesis, 3, 303 Erythrosine application, 3, 879 Esculetin... [Pg.622]

In some cases enzymes can increase the rate of reaction by up to lO times. Carnell and Roberts (1997) have briefly discussed the scope of biotransformations that are used to make pharmaceuticals like penicillins, cephalosporines, erythromycin, lovastatin, cyclosporin, etc., and for food additives like citric acid, L-glutamate, and L-lysine. A very successful transformation by Zeneca has been that of benzene reduction, with Pseudomonase Putida, to dihydrocatechol and catechol the dihydro derivative is used to produce (+/-) pinitol. Fluorobenzene has been converted to fluorodihydrocatechol, an intermediate for pharmaceuticals. The highly stereo selective Bayer-Villeger reaction has been carried out with genetically engineered S-cerevisvae. Hydrolases have allowed enantioselective, and in some cases regioselective, hydrolysis of racemic esters. [Pg.157]

Stuer et al. [46] evaluated the presence of the 25 most used pharmaceuticals in the primary health sector in Denmark (e.g., paracetamol, acetyl salicylic acid, diazepam, and ibuprofen). They compared PECs with experimental determinations and they conclude that measured concentrations were in general within a factor of 2-5 of PECs. Carballa et al. [45] also determined PECs for pharmaceuticals (17), musk fragrances (2) and hormones (2) in sewage sludge matrix. For that purpose they used three different approaches (1) extrapolation of the per capita use in Europe to the number of Spanish inhabitants for musk fragrances (2) annual prescription items multiplied by the average daily dose for pharmaceuticals and (3) excretion rates of different groups of population for hormones. They indicated that these PECs fitted with the measured values for half of them (carbamazepine, diazepam, ibuprofen, naproxen, diclofenac, sulfamethoxazole, roxithromycin, erythromycin, and 17a-ethiny I e strad iol). [Pg.37]

Since the order of increasing CL intensity for alkyl amines reacted with Ru(bpy)32+ is tertiary amines > secondary amines > primary amines, pharmaceutical compounds bearing a tertiary amine function (e.g., antihistamine drugs [99], anticholinergic drugs [100], erythromycin [101], and its derivatives [102]) have been sensitively determined after HPLC separation (Table 3). The method was applied to the detection of d- and L-tryptophan (Trp) after separation by a ligand-exchange HPLC [103], The detection limits for d- and L-Trp were both 0.2 pmol per injection. Oxalate in urine and blood plasma samples has also been determined by a reversed-phase ion-pair HPLC (Fig. 18) [104], Direct addition of... [Pg.419]

The polyketides are a large family of bio synthetically related NPs, some of which have very great pharmaceutical value (polyketide sales total about 10 billion annually, see also Chapter 7). Some antibiotics (erythromycin, monensin, rifamycin), immunosuppressants (rapamycin), antifungal substances (amphotericin), antiparasitic (aver-mectin) and anticancer drugs (doxorubicin) are polyketides. The term polyketide refers to the fact that the basic carbon skeleton is not a simple hydrocarbon chain as in the case of fatty acids but is a series of linked keto groups in sequence (Figure 3.6). The first phase of this pathway, the generation of carbon skeleton diversification. [Pg.68]

Each Member State has to evaluate its own water quahty, identify why some areas do not reach the required standard, and then implement improvement plans. If a pharmaceutical residue is perceived to be contributing to the poor water quahty it is probable that an environmental quahty standard will be set for it. Comphance with this standard will then be needed, and this can only be accomplished by improving wastewater treatment or restricting sales. Draft standards have aheady been set in Germany for carbamazepine (0.5 pgL" ), diclofenac (0.1 ig I. ), erythromycin (0.02pgL ), ibuprofen (7.1 pg I, ), and metoprolol (7.3pgL ) [31], and in the United Kingdom for 17a-ethinyl estradiol (0.0001 pgL ). [Pg.97]

The over 2(H) known members of the class of compounds known as macro ide antibiotics1 includes several active substances, such as erythromycin (sir Chapter 6), that are highly prized as backup medications drugs to which one can resort when resistance develops lo more conventional pharmaceuticals... [Pg.233]

A final example of metabolic pathway engineering is based on polyketide and nonribosomal peptide biosynthesis. Polyketides and nonribosomal peptides are complex natural products with numerous chiral centers, which are of substantial economic benefit as pharmaceuticals. These natural products function as antibiotics [erythromycin A (65), vancomycin (66)], antifungals (rapamycin, amphotericin B), antiparasitics [avermectin Ala (67)], antitumor agents [epothiolone A (68), calicheamicin yj, and immunosuppressants [FK506 (69), cyclosporin A], Because this exponentially growing and intensely researched field has developed, the reader is directed to review articles for additional details.347-359 Also with the potential economic benefit to develop the next blockbuster pharmaceutical, a number of patents and patent applications have been published.360-366... [Pg.387]

Macrolides and polyethers such as erythromycin A (4), FK 506, rapamycin or avermectin A (5, Scheme 1) are products of modular type I polyketide-synthases. These compounds are distinguished by extraordinary structural diversity and complexity [1,2]. Because of their biological potency, members of this structural class as well as the aromatic polycyclic products of type II polyketide-synthases, tetracyclines and anthara-cyclines, e.g. adriamycin (6), became useful as pharmaceuticals (antibiotics, cytostatics, immunosuppressives) [1,2],... [Pg.343]

For an overview of Abbott, see Derdak, ed., International Directory, vol. 11 (1995), pp. 7-9 Taggart, World Pharmaceutical Industry, pp. 185-186 Stopford, Directory of Multinationals. For erythromycin, see Temin, Taking Your Medicine, pp. 77-78. [Pg.334]

Natural products represent a diversity of chemical compounds with varied biological activities. Natural products are an important source of novel pharmaceuticals as well as agricultural pesticides (1,2). Natural products are derived from a number of pathways that create basic scaffolds that are further modified by various tailoring enzymes to create the wide diversity of structures that exist in nature. Polyketide synthases are responsible for the synthesis of an array of natural products including antibiotics such as erythromycin in bacteria (3) and mycotoxins such as aflatoxin in fungi (4). Furthermore, in plants they are part of the biosynthetic machinery of flavonoids, phytoalexins, and phenolic lipi (5,6). [Pg.142]

The polyketides are a family of natural products containing many important pharmaceutical agents that are synthesized through the multienzyme complex, polyketide synthase, which can display substantial molecular diversity with respect to chain length, monomer incorporated, reduction of keto groups, and stereochemistry at chiral centers (189). This variability, together with the existence of several discrete forms of polyketide synthase, allows the generation of diverse structures like erythromycin, avermectin, and rapamycin. This biochemical diversity has been considerably expanded by the introduction of new sub strate species that were used by the enzymes to produce new or unnatural polyketides (190). [Pg.350]

Erythromycin Pharmaceutical formulations Chloroform Fluorimetry 0.68 pg mL 1 C-FIA membrane for phase separation ion pair formation with ETB [463]... [Pg.351]

A. Sanz, V. Tomas, C. Martinez-Lozano, T. Perez-Ruiz, Extraction-spectrofluorimetric method for the determination of erythromycin and its esters in pharmaceutical formulations using manual and flow-injection procedures, Analyst 118 (1993) 567. [Pg.443]


See other pages where Pharmaceuticals erythromycin is mentioned: [Pg.130]    [Pg.130]    [Pg.98]    [Pg.203]    [Pg.218]    [Pg.62]    [Pg.255]    [Pg.102]    [Pg.229]    [Pg.232]    [Pg.287]    [Pg.63]    [Pg.160]    [Pg.161]    [Pg.138]    [Pg.159]    [Pg.558]    [Pg.224]    [Pg.273]    [Pg.165]    [Pg.240]    [Pg.1312]    [Pg.399]    [Pg.686]    [Pg.16]    [Pg.2]    [Pg.58]    [Pg.86]    [Pg.622]    [Pg.386]    [Pg.21]    [Pg.199]    [Pg.288]    [Pg.72]    [Pg.39]    [Pg.92]   
See also in sourсe #XX -- [ Pg.62 ]




SEARCH



Erythromycine

© 2024 chempedia.info